Home Sulfonamines 4392-54-5
4392-54-5,MFCD00625132
Catalog No.:AA00I8AJ

4392-54-5 | 4-Hydrazinobenzenesulfonamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$20.00   $14.00
- +
1g
96%
in stock  
$53.00   $37.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00I8AJ
Chemical Name:
4-Hydrazinobenzenesulfonamide
CAS Number:
4392-54-5
Molecular Formula:
C6H9N3O2S
Molecular Weight:
187.2196
MDL Number:
MFCD00625132
SMILES:
NNc1ccc(cc1)S(=O)(=O)N
NSC Number:
73246
Properties
Computed Properties
 
Complexity:
226  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
3  
Rotatable Bond Count:
2  
XLogP3:
-0.1  

Literature

Title: Synthesis and antimicrobial evaluation of some pyrazole derivatives.

Journal: Molecules (Basel, Switzerland) 20120430

Title: 2-(4-Sulfamoylphen-yl)hydrazin-1-ium chloride.

Journal: Acta crystallographica. Section E, Structure reports online 20120401

Title: 4-[5-(Furan-2-yl)-3-trifluoro-methyl-1H-pyrazol-1-yl]benzene-sulfonamide.

Journal: Acta crystallographica. Section E, Structure reports online 20120401

Title: Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.

Journal: European journal of medicinal chemistry 20120301

Title: Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.

Journal: Bioorganic & medicinal chemistry 20120215

Title: Synthesis and biological evaluation of some novel sulfamoylphenyl-pyridazinone as anti-inflammatory agents (Part-II * ).

Journal: Journal of enzyme inhibition and medicinal chemistry 20120201

Title: 4-(5-Phenyl-3-trifluoro-meth-yl-1H-pyrazol-1--yl)benzene-sulfonamide.

Journal: Acta crystallographica. Section E, Structure reports online 20110901

Title: 4-(3-Methyl-5-phenyl-1H-pyrazol-1-yl)benzene-sulfonamide.

Journal: Acta crystallographica. Section E, Structure reports online 20110901

Title: 4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzene-sulfonamide.

Journal: Acta crystallographica. Section E, Structure reports online 20110901

Title: 4-(5-Oxo-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)benzene-sulfonamide.

Journal: Acta crystallographica. Section E, Structure reports online 20110901

Title: 4-(3-Methyl-4,5-dihydro-1H-benzo[g]indazol-1-yl)benzene-sulfonamide.

Journal: Acta crystallographica. Section E, Structure reports online 20110901

Title: Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.

Journal: Bioorganic & medicinal chemistry 20110815

Title: A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.

Journal: Bioorganic & medicinal chemistry 20110201

Title: Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents.

Journal: European journal of medicinal chemistry 20100601

Title: 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20100515

Title: Synthesis and biological evaluation of some novel 6-aryl-2-(p-sulfamylphenyl)-4,5-dihydropyridazin-3(2H)-ones as anti-cancer, antimicrobial, and anti-inflammatory agents.

Journal: Journal of enzyme inhibition and medicinal chemistry 20100401

Title: Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.

Journal: Journal of medicinal chemistry 20100311

Title: Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.

Journal: Bioorganic & medicinal chemistry letters 20070701

Title: Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.

Journal: Journal of medicinal chemistry 20070125

Title: Liquid-chromatographic separation and determination of process-related impurities, including a regio-specific isomer of celecoxib on reversed-phase C18 column dynamically coated with hexamethyldisilazane.

Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20060901

Title: Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.

Journal: Bioorganic & medicinal chemistry letters 20060415

Title: QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.

Journal: Bioorganic & medicinal chemistry letters 20060401

Title: Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.

Journal: Journal of medicinal chemistry 20060323

Title: Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.

Journal: Journal of medicinal chemistry 20051201

Title: Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20050901

Title: Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20050215

Title: Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20050215

Title: Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20041220

Title: Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.

Journal: Bioorganic & medicinal chemistry letters 20041115

Title: Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20040621

Title: Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.

Journal: Bioorganic & medicinal chemistry letters 20030324

Title: Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.

Journal: Journal of medicinal chemistry 20020328

Title: Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.

Journal: Bioorganic & medicinal chemistry letters 20010226

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:4392-54-5 Molecular Formula|4392-54-5 MDL|4392-54-5 SMILES|4392-54-5 4-Hydrazinobenzenesulfonamide